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Background: CREBZF is a member of the mammalian ATF/CREB family of the basic region-leucine zipper (bZIP)
transcription factors. Two isoforms of CREBZF have been identified from the alternative usage of initiation codons,
SMILE (long isoform of CREBZF) and Zhangfei (short isoform of CREBZF). Until recently, the physiological function of
CREBZF in mammalian reproductions has not been reported.
Methods: Multiple techniques were performed to investigate the spatiotemporal expression and hormonal
regulation of the CREBZF gene in the mouse uterus and its role in embryo implantation.
Results: Zhangfei was not detected in the mouse uterus. SMILE immunostaining was mainly expressed in the
uterine luminal and glandular epithelium, and the expression levels of both SMILE mRNA and protein gradually
decreased from days 1–3 of pregnancy, peaked on day 4, and then declined again on day 6. On day 5 of
pregnancy, SMILE protein expression was detected only in the luminal epithelium at implantation sites compared
with the expression at inter-implantation sites. SMILE protein was not detected in decidual cells from days 6–8 of
pregnancy or artificial decidualisation. Furthermore, SMILE protein was not detected in the mouse uterus on days
3–6 of pseudopregnancy, and SMILE expression was also induced in the delayed-implantation uterus, indicating
that the presence of an active blastocyst was required for SMILE expression at the implantation site. Oestrogen
significantly stimulated SMILE expression in the ovariectomised mouse uterus. In addition, in cycling mice, high
levels of SMILE protein and mRNA expression were also observed in proestrus and oestrus uteri.
Conclusions: Taken together, these results suggested that SMILE expression was closely related to mouse
implantation and up-regulated by oestrogen.
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Successful implantation is dependent on the intricate
genetic and molecular signalling dialogue between the
receptive uterus and active embryo [1]. A better under-
standing of the molecular events underlying the regulation
of embryo implantation may improve the ability to treat
infertility. To date, although many molecular modulators
have been identified during the implantation period,
the precise molecular mechanism underlying embryo
implantation is still unknown.
CREBZF is as a member of the CREB (cAMP-response-
element-binding protein)/ATF (activating transcription* Correspondence: aihuawang1966@163.com
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stated.factor) family of basic region-leucine zipper (b-ZIP)
transcription factors [2]. Previously studies have found
that CREBZF gene expression produces two isoforms,
CREBZF-L (long isoform of CREBZF, also known as SMILE)
and CREBZF-S (short isoform of CREBZF, which was
previously designated as Zhangfei or ZF) [3]. However,
unlike other b-ZIP proteins CREBZF lacks the ability to
bind any of the consensus recognition elements for b-ZIP
proteins and cannot activate promoters containing these
motifs [2,4]. Instead, CREBZF requires heterodimerisation
with other factors to bind target promoters and to regulate
downstream genes, which may include VP16 [5], Luman
(or CREB3, L-ZIP) [6], Activating transcription factor 4
(ATF4, or CREB2) [7], X-box-binding protein-1 (XBP1)
[8] and tropomyosin-related kinase A (trkA) [9,10]. A. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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these promoters may be the absence of a critical asparagine
residue in its basic domain, which forms the DNA-
recognition motif, NxxAAxxCR, in all b-ZIP proteins [2,4].
Zhangfei was first identified via its interaction with
the Herpes Simplex Virus-1 (HSV-1)-related cellular
protein Host Cell Factor 1 (HCF-1) and has been proposed
to play a role in inhibiting the replication of the
herpes simplex virus [2,5]. Recent studies have shown
that Zhangfei could potentially play an important role
in the mammalian unfolded protein response (UPR)
[6-8]. Zhangfei might activate apoptosis in ONS-76
medulloblastoma cells via the NGF/TrkA pathway [10,11].
Currently, the precise physiological function of SMILE
remains unclear. Recently, SMILE has been reported as
a novel transcriptional co-regulator of a variety of nuclear
receptors, including oestrogen receptors, glucocorticoid
receptor, constitutive androstane receptor, hepatocyte
nuclear factor 4α and oestrogen receptor-related receptor
γ [3,12,13]. In another study, SMILE played an important
role in the development of beta cell dysfunction induced
by glucolipotoxicity [14]. Zhangfei exhibits a liver- and
cell-type-specific expression pattern; however, SMILE is
expressed ubiquitously in mouse tissues and tumour-
derived cells [3]. Thus, it is certainly possible that the
two isoforms exhibit different regulatory functions in
specific cellular contexts. However, until recently, the
physiological function of CREBZF in mammalian repro-
duction has not been reported. To explore the potential
function of CREBZF during pregnancy, we sought to
investigate in detail the expression and regulation of
CREBZF mRNA and protein in the mouse uterus during
the oestrous cycle and peri-implantation period.
Methods
Animals and treatments
The experimental use of mouse for this study was
performed according to the Committee for the Ethics
on Animal Care and Experiments in Northwest A&F
University. Mature mice (Kunming White outbred strain,
8-to 10-wk-old) were purchased from the laboratory
animal centre of Xi’An JiaoTong University and housed
at a temperature- (24+/−2°C) in a light-controlled room
(12 h light: 12 h darkness) with free access to food and
water.
Oestrous cycles were tracked by performing daily vaginal
smears, and only those mice that demonstrated a regular
4-day oestrous cycle were used for these experiments.
Mouse models of early pregnancy, pseudopregnancy,
delayed implantation and activation, artificial decidualisation
and hormonal treatment were produced as described in
our previous reports [15,16]. Eight mice were used in
each stage or treatment in this study. To confirm the
reproducibility of the results, each sample was analysedin triplicate. The entire uterus was collected immediately
following sacrifice by cervical dislocation, and half of each
uterus was immediately processed for immunohistochem-
istry, whereas the remaining half was frozen in liquid
nitrogen for further extraction of total RNA and protein.
Embryo collection
Female mice were superovulated via an intraperitoneal
injection of 5 IU of pregnant mare’s serum gonadotrophin
(PMSG, Ningbo Sansheng Pharmaceutical Co., Ltd. China)
at 4:00 pm followed by human chorionic gonadotrophin
(hCG, Ningbo Sansheng Pharmaceutical Co., Ltd. China)
48 hr later. Treated female mice were mated with fertile
males of the same strain to induce natural pregnancy.
Embryos at the zygote, 2-cell and 4-cell stage were collected
from oviducts at 24 hr, 46 hr and 54 hr, respectively.
However, the 8-cell stage embryo, morula and blastula
were collected from the uterine horns at 68 hr, 72 hr
and 96 hr, respectively. A total of 160 mice were used
for embryo collection and 35–40 pooled embryos per
developmental stage were analyzed in each group. Three
independent experiments were performed.
RNA extraction, cDNA synthesis and real-time
quantitative PCR
Total RNA was extracted from the uterine horns and
embryo using Trizol (Invitrogen, Inc., Carlsbad, CA, USA)
according to the manufacturer’s instructions. DNase (TaKaRa
Bio, Inc., Dalian, China) was used to remove genomic
DNA contamination prior to RT. Extracted RNA was
dissolved in diethylpyrocarbonate (DEPC)-treated water,
and the RNA concentration and purity were estimated
by reading the absorbance at 260 and 280 nm on a
spectrophotometer (Eppendorf, Inc., Hamburg, Germany).
The cDNAs were synthesised using PrimeScriptTM RT
reagent Kit (TaKaRa Bio, Inc., Dalian, China) according
to the manufacturer’s instructions. The final volume of
the reaction was 20 μl, including 800 ng of total RNA.
The reverse transcription product was stored at −20°C.
The GenBank accession number of the mRNA, primer
sequences and annealing temperatures are listed in Table 1.
Real-time PCR was performed using three biological
replicates and technical triplicates/duplicates of each
cDNA sample in the LightCycler system (iQ5, Bio-Rad
Laboratories, Inc., Hercules, USA) using SYBR® Premix
Ex TaqTM II Kit (TaKaRa Bio, Inc., Dalian, China), according
to the manufacturer’s protocol. Each PCR reaction (total
volume of 20 μl) consisted of 2 μl reverse transcription
product, 0.8 μl of each 10 μM forward and reverse primer,
10 μl SYBR® Premix Ex TaqTM II, and 6.4 μl RNase-free
water. The cycling conditions included a denaturation step
at 95°C for 30 sec, followed by 45 PCR cycles of 95°C for
5 sec and 60°C for 20 sec. A melting curve analysis was
performed at the end of each PCR program to exclude
Table 1 The primer sequences used for real-time quantitative PCR
Target gene GenBank accession no. Primer sequence Product size (bp) Annealing temperature (°C)
SMILE NM_145151.2 AF: 5'-TAATCGGCTCAAGAAGAAGG-3' 144 60
AR: 5'-CGTAGGTAGCGACTCTCC-3'
RPLP0 NM_007475 AF:5'- GGACCCGAGAAGACCTCCTT-3' 85 60
AR:5'- GCACATCACTCAGAATTTCAATGG-3'
GAPDH NM_008084 AF:5'- TCACTGCCACCCAGAAGA-3' 186 60
AR:5'- GACGGACACATTGGGGGTAG-3'
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quantifications were performed using the 2-△△Ct method
and the amount of transcripts in each sample was
normalised using RPLP0 and GAPDH as the internal
control gene to correct for differences in the amount of
cDNA used [17,18].
Immunohistochemistry
Uterine tissues were fixed in 4% (v/v) paraformaldehyde
(Sinopharm Chemical Reagent Co., Ltd, Shanghai, China)
in phosphate-buffered saline (PBS; pH 7.4) for 24 hr,
dehydrated through a graded ethanol series, and embedded
in paraffin. Five μm-thick sections were mounted onto
glass slides that were precoated with poly-L-Lysine
solution (Sigma, St. Louis, MO, USA) and incubated
overnight at 37°C. After dehydration, the samples were
placed in citrate buffer (pH 6.0), and antigen retrieval
was performed by treating the samples (twice) in a
microwave oven at 750 W for 5 min. The slides were then
washed in PBS. Sections were pretreated with 0.3% (v/v)
H2O2 in methanol to quench endogenous peroxidase
activity. After several washes with PBS, the sections were
incubated with 10% rabbit serum for 30 min at 37°C.
Following blocking, the sections were incubated with
goat anti-CREBZF polyclonal antibody (Santa Cruz,
sc-49328; diluted 1:200 with PBS) for 12 hr at 4°C,
washed with PBS, and incubated with biotinylated anti-
goat IgG antibody (MaiXin-Bio Technology Co., Ltd.,
Fuzhou, China) for 1 hr at 37°C. Sections were washed
three times with PBS, and then incubated with HRP-
labelled streptavidin (SA-HRP) for 30 min at 37°C. Next,
positive reactions were visualised using a diaminoben-
zidine (DAB)-peroxidase substrate (Sigma-Aldrich Co.
LLC, Louis, MO, USA) and 30 sec counterstaining with
haematoxylin. Negative control slides without the addition
of primary antibody or substitution with an appropriate
dilution of normal goat IgG was performed in parallel.
Slides were imaged using a digital microscope (BA400,
Motic, Wetzlar, Germany).
Western blotting analyses
Proteins obtained from uterine tissues were extracted
using the Total Protein Extraction Kit (Nanjing KeygenBiotech Co., Ltd., Nanjing, China) according to the
supplier’s instructions. The total protein per sample
was separated using 12% sodium dodecyl sulphate (SDS)-
polyacrylamide gel electrophoresis (PAGE) followed by
electrotransfer to polyvinylidene fluoride (PVDF) membranes
(Millipore; Bedford, MA). The membrane was treated with
blocking buffer (5% nonfat dried milk in Tris-buffered
saline [TBS] containing 0.1% Tween 20) for 1 hr at
room temperature and incubated overnight at 4°C with
antibodies against CREBZF (Santa Cruz, sc-49328;
1:500 dilution) or β-actin (1:1,000; Beijing CWBIO Co.,
Ltd., Beijing, China) as a loading control. The membranes
were washed three times with TBS, and then incubated
with biotinylated anti-goat IgG antibody or biotinylated
anti-mouse IgG antibody (1:5,000; MaiXin-Bio Technology
Co., Ltd., Fuzhou, China) for 1 hr at room temperature.
After washing, the membranes were incubated with
SA-HRP for 30 min at room temperature. Finally, the
immunoreactive bands were visualised by DAB staining
(Sigma) at room temperature for 5 min, and the immuno-
reactive bands were imaged using a digital microscope
(Tanon-4100, Tanon Science & Technology Co., Ltd.,
Shanghai, China) and densitometric analyses were proc-
essed with Quantity one v4.62 (Bio-Rad).
Immunofluorescence
Embryos were fixed in 4% paraformaldehyde for 30 min
at room temperature followed by permeabilising in 0.5%
Triton X-100 in PBS. After washing in PBS, the embryos
were treated with blocking solution of 1% bovine serum
albumin in PBS for 1 hr, followed by incubation with goat
anti-CREBZF polyclonal antibody (Santa Cruz, sc-49328;
1:500 dilution) at 4°C overnight. Embryos were then
washed three times with PBS, and incubated for 1 hr at
room temperature in a 1:500 dilution of Cy3-labelled
donkey anti-goat IgG (Beyotime Institute of Biotechnology,
Jiangsu, China). The nuclei were stained with 4,6-diami-
dino-2-phenylindole (DAPI). Embryos were viewed under
a laser-scanning confocal microscope (A1R, NiKon).
Additionally, negative control embryos per developmental
stage were treated in the same manner as described
above, but omitting the primary antibody or primary
and secondary antibodies, respectively.
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All experiments were replicated at least three times for
each group and the data were presented as the mean ± S.
E.M. Data were analysed using ANOVA, followed by
Fisher’s Least Significant Different Test (Fisher LSD) and
Independent-Samples T test with SPSS software (Version
13.0; SPSS, Inc., Chicago, IL). Differences were considered
significant when P < 0.05.
Results
CREBZF protein expression in the mouse uterus
Changes in CREBZF protein expression in whole uterine
protein extracts were detected using western blotting
analyses. In all samples analysed, a single band at
approximately 50–60 kDa was observed (Figure 1). Xie
et al. [3] reported that SMILE and Zhangfei isoforms
were apparent at molecular masses of 50–60 kDa and
40 kDa, respectively. These results indicated that SMILE
was the predominant form in this study, whereas Zhangfei
was not detected in the mouse uterus.
The positive control for SMILE and Zhangfei protein
was analysed by western blotting using a CREBZF-specific
antibody. Results are representative of at least three inde-
pendent experiments with similar results. MCF7, human
breast adenocarcinoma cell line. 293 T, human embryonic
kidney cell line (Additional file 1: Figure S1).
SMILE is expressed in the mouse uterus throughout the
oestrus cycle
To determine whether there are differences in the expres-
sion and localisation of SMILE mRNA and protein during
the oestrus cycle, SMILE mRNA and protein expression
in the mouse uterine at proestrus, oestrus, metestrus
and diestrus was detected using immunohistochemistry,
real-time PCR and western blotting, respectively. We
found that independent of the phase of the oestrus cycle,
SMILE protein was specifically expressed in the endomet-
rial epithelial cells of both the lumen and glands, while
the expression was most prominent at the oestrus phase
(Figure 2A). Real-time PCR and western blotting analysis
also revealed that the levels SMILE mRNA and protein at
oestrus were significantly higher compared to the levels
from metestrus and diestrus, although these values were
not significantly different compared with those obtained
from the proestrus phase (P < 0.05, Figures 1A and 2B).
SMILE expression during early pregnancy
SMILE protein was mainly localised in the luminal and
glandular epithelium during days 1 to 5 of pregnant uteri,
whereas the staining intensity on day 4 of pregnancy was
significantly increased (Figure 3 D1-D5). Compared
with the inter-implantation site, the positive signal was
observed in the luminal epithelium at the implantation
site on day 5 of pregnancy (Figure 3 D5N and D5I). Noobvious immunostaining of the SMILE protein was
detected in the decidual cells, and SMILE only presented
in the remaining glandular epithelium from days 6–7 of
pregnancy (Figure 3 D6 and D7). Moreover, no specific
signal for SMILE protein was detected in the artificial
decidualisation model, and SMILE mRNA expression also
did not show a significant difference in the decidualised
uterus compared with the control uterus (data not
shown).
Real-time PCR was also used to detect the levels of
SMILE mRNA expression in the mouse uterus on days
1–7 of pregnancy (Figure 4A). SMILE mRNA levels were
gradually decreased on days 1–3 of pregnancy and were
significantly lower on day 3 compared to day 1. These
levels then peaked on day 4 (P < 0.05, Figure 4A). However,
the level of SMILE mRNA was significantly decreased in
the mouse uterus as the decidua was developing from day
6 to 7 of pregnancy. Similar with the results obtained from
real-time PCR, SMILE protein was gradually decreased
from day 1 to day 3, but it was up-regulated in day 4 uteri
and was nearly not detectable from day 6 to day 7 uteri
(Figure 1B).
SMILE expression during pseudopregnancy and
activated implantation
In pseudopregnant mice, a basal level of SMILE staining
was observed in luminal and glandular epithelium on
days 1–2; however, no positive staining was observed in
the uterus from day 3–6 (data not shown). Compared to
early pregnancy, the levels of both SMILE mRNA and
protein were lower on day 2 in pseudopregnant uteri
(Figures 1C and 4A). As shown in Figure 3, SMILE
immunostaining was abundantly expressed in activated
implantation uteri, while its staining was weakly expressed
in delayed implantation uteri. Moreover, significantly
higher levels of SMILE mRNA and protein were also
induced in the activated implantation uterus compared
with the levels in the delayed uterus (P < 0.05, Figures 1D
and 4B). Taken together, these observations strongly
suggested that the presence of embryos affected SMILE
localisation in these epithelial cells.
Steroid hormonal regulation of SMILE expression
Because E2 and P4 are essential for mouse embryo im-
plantation, ovariectomised mice were used to examine
the effects of steroid hormones on CREBZF expression.
We found no visible signal in the ovariectomised mice
(Figure 3). In the P4-treated group, a low level of SMILE
immunostaining was present in the luminal and glandular
epithelium. However, E2 significantly induced the expres-
sion of SMILE protein both in the luminal and glandular
epithelium. There was only a moderate level of SMILE
expression in these cells via combined E2 and P4 treatment.
To further confirm SMILE expression, real-time PCR
AE
























Figure 1 Immunoblot analysis for CREBZF proteins in the mouse uterus during oestrous cycle (A), early pregnancy (B), pseudopregnancy
(C), delayed implantation (D), and steroid hormonal treatments (E). β-actin levels are shown as a loading control. The values represent the
mean ± S.E.M. from three duplicates, and the bar bearing different superscript indicates a significant difference between the mean values (P < 0.05).
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difference in SMILE mRNA expression was observed
after an injection of P4 compared to that of oil treatment
(Figure 4C). In contrast, the expression levels of SMILE
mRNA and protein in the uterus were significantly stimu-
lated by E2 treatment (P < 0.05, Figures 1E and 4C). After
the combined injection of E2 and P4, the SMILE mRNAand protein expression in uterus were similar to those in
the E2 treatment alone, respectively.
Localisation of SMILE in mouse embryos during the
peri-implantation period
To further study the role of SMILE in embryo implant-
ation, we examined its localisation in the mouse embryos
A
Proestrus Estrus Metestrus
Diestrus Negative controls B
Figure 2 Expression of SMILE in the mouse uterus during different phases of the oestrus cycle. (A) Immunolocalisation of SMILE protein
in the luminal and glandular epithelial cells of the uterus during the mouse oestrous cycle. Bars =25 μm. (B) Expression of SMILE mRNA in cycle
uteri as detected using real-time PCR. The values represent the mean ± S.E.M. from three duplicates, and the bar bearing different superscript
indicates a significant difference between the mean values (P < 0.05).
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demonstrated that SMILE was expressed at all stages of
mouse pre-implantation embryos and was mainly localised
in the cytoplasm and nucleus (Figure 5A). At the blasto-
cyst stage, strong signals of SMILE protein were observed
in the trophectoderm and the inner cell mass (Figure 5A).
Furthermore, the levels of SMILE mRNA were gradually
increased from the zygote to the blastocyst stage in the
embryo (P < 0.05, Figure 5B).
Discussion
This study mainly reported on the changes in the
expression of two isoforms of CREBZF, as well as their
cellular localisation throughout the oestrous cycle and
peri-implantation period in the mouse uterus. These results
idicated that SMILE was the predominant form and
Zhangfei was not detected in the uterus, which was consist-
ent with the expression pattern of SMILE in the male
mouse prostate and testis [3]. Moreover, our results sug-
gested that SMILE had a cycle-dependent expression in
mouse uterus and was clearly localised in both luminal and
glandular epithelial cells. A relatively higher expression of
SMILE mRNA and protein at the oestrus phase accompan-
ies the female as she reaches optimal sexual receptivity and
ovulating time. Thus, we speculated that the elevated levels
of SMILE might contribute to the induction of embryo
earlier during development and implantation. Indeed,
SMILE was localised in the cytoplasm and nucleus of
mouse pre-implantation embryos, and the level of SMILE
mRNA was gradually increased with embryo development.
In addition, SMILE was expressed at high levels in theluminal and glandular epithelium at the proestrus and
oestrus phase, and at basal levels in the metestrus and dies-
trus phase. These data also suggested that SMILE might be
under cell-specific sex hormonal control in the mouse uter-
ine epithelium and appeared to be important factors for
implantation.
During pregnancy the uterus undergoes a series of
programmed morphological changes, resulting in an
extensive tissue reorganisation to accommodate the
growing embryo [19]. The time from days 1 to 5 of
pregnancy is critical for embryo implantation in mice, and
days 4 to 5 of pregnancy is regarded as the implantation
window. The embryo apposes and attaches to the uter-
ine luminal epithelium, which is the initial step for a
successful pregnancy [20]. The expression levels of
SMILE mRNA and protein were gradually decreased in
the mouse uterus from days 1 to 3, but were sharply
up-regulated on day 4. Furthermore, the uterine expression
of the SMILE protein in the luminal epithelium was
predominantly localised at the implantation site on days
5 of pregnancy, demonstrating temporal and spatial
specificity during the period of mouse embryo implantation.
Taken together, these results suggested that SMILE
might play an essential role in the initial attachment of
a blastocyst to the uterine epithelia in the mouse. How-
ever, the up-regulation of SMILE was restricted to day 5
and was not expressed in decidualised cells on days 6–7
of early pregnancy or under artificial decidualisation,
although SMILE was also highly expressed in glandu-
lar epithelial cells, which might not be important for
decidualisation.











































Figure 3 Localisation of SMILE protein in the mouse uterus during early pregnancy, delayed and activated implantation and steroid
hormonal treatments, examined by immunohistochemistry. D1-D7, the sections were stained with CREBZF antibody for days 1–7 pregnant
uterus; D5I, implantation sites on day 5 of pregnancy; D5N, inter-implantation sites on day 5 of pregnancy. L = luminal epithelium; G = glandular
epithelium; S = stromal cells; D = decidual cells; E = embryo. Bars =25 μm.
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1–2 in the pseudopregnant uteri and was not observed in
the uterus from days 3–6 of pseudopregnancy, indicating
that SMILE expression was dependent on the presence
of the embryo. Moreover, SMILE mRNA and protein
were highly expressed in the uterus when the delayed
implantation was terminated by via treatment compared
with the expression under conditions of delayed implant-
ation. In addition, the localisation of SMILE protein in
the trophectoderm and increased expression of SMILE
mRNA and protein at the blastocyst stage might be aprerequisite for establishing contact between the blastocyst
and uterine epithelium. These results suggested that SMILE
expression in the mouse uterus required the presence of an
active blastocyst during the peri-implantation period.
Implantation has long been known to be a steroid
hormone-dependent process. The coordinated action of
both E2 and P4 is necessary for the preparation and
process of implantation in the mouse endometrium [21].
Because both E2 and P4 are essential for the induction of
implantation in the mouse, we examined the hormonal
regulation of SMILE expression. It has been reported that
A B C
Figure 4 Relative levels of SMILE mRNA in the mouse uterus during early pregnancy and pseudopregnancy. (A), delayed implantation
(B) and steroid hormonal treatments (C) were assessed using real-time PCR. SMILE expression was normalised to RPLP0 and GAPDH. The values
represent the mean ± S.E.M from three independent experiments. Bars with different letters are significantly different (P < 0.05).
Lin et al. Reproductive Biology and Endocrinology 2013, 11:110 Page 8 of 9
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activation of oestrogen receptors via a small heterodimer
partner in a cell-type-specific manner, although CREBZF
isoforms did not interact directly with oestrogen receptors
[3]. CREBZF isoforms as a novel corepressor of nuclear
receptors may interact with SIRT1 to regulate the
transactivation of oestrogen receptor-related receptor γ
[13]. SIRT1 plays an important role in the development
of human uterine receptivity via inducing E-cadherin
expression [22]. Our studies found that E2 could signi-
ficantly up-regulate the expression and localisation of
SMILE in the luminal epithelium and glandular epithelial
cells in ovariectomised mice. In addition, P4 had no signifi-
cant effects on SMILE expression in the ovariectomised
mouse uterus. Similar hormonal regulation was also















Figure 5 Expression of SMILE mRNA and protein in the mouse embry
SMILE protein in embryos from the zygote to the blastocyst stage. The red
nuclear staining. Bar = 20 μm. (B) Analysis of SMILE mRNA levels using real-
M from three independent experiments. Bars with different letters are signmRNA and protein in the mouse uterus during the
oestrous cycle in this study. High levels of E2 were
observed in mice during proestrus and oestrus, de-
creasing to low levels during metestrus and diestrus
[23]. During normal mouse pregnancy, higher levels of
E2 were detected on day 1 and day 4, a surge in E2 on
day 1 stimulated uterine epithelial cell proliferation
and induced the expression of progesterone receptors.
An increase in E2 levels on day 4 combined with the
high P4, which further stimulated uterine stromal prolifer-
ation and induced the endometrial receptivity for the
blastocyst to implant [21,24]. The results in ovariecto-
mised mice, oestrous cyclic mouse in pregnant mice
confirmed our supposition that the expression of
SMILE in the peri-implantation uterus may be mainly














os during pre-implantation. (A) Immunofluorescence analyses of
colour represents SMILE staining, and the blue colour indicates
time PCR in the mouse embryos. The values represent the mean ± S.E.
ificantly different (P < 0.05).
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On the basis of these findings, we concluded that SMILE
might play a potential role in mediating uterine receptivity
during implantation and development of preimplantation
embryos in mice. Moreover, SMILE expression in mouse
uteri was regulated by active blastocysts and E2.
Additional file
Additional file 1: The positive control for SMILE and Zhangfei protein
was analysed by western blotting using a CREBZF-specific antibody.
Results are representative of at least three independent experiments with
similar results. MCF7, human breast adenocarcinoma cell line. 293 T, human
embryonic kidney cell line.
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